fashion -WSS

fashion

author：explore 2025-09-30 16:29:23 - browse：51

Adobe

The Food and Drug Administration has cleared Otsuka Pharmaceutical’s digital treatment for major depressive disorder, offering a new option for millions of people who struggle with the stubborn mental health condition.

Called Rejoyn, the smartphone-based treatment for major depressive disorder symptoms was developed with digital health company Click Therapeutics, and it is intended for use by prescription alongside antidepressants. The six-week program delivers a novel “cognitive-emotional training” technique, in which people are asked to identify and recall faces showing different emotions. Researchers hypothesize that the technique targets the brain’s dorsolateral prefrontal cortex and the amygdala and may “enhance cognitive control over emotional information processing.” Patients also receive cognitive behavioral therapy.

Rejoyn has been in development since 2018, and Otsuka is the first drug company to receive FDA clearance for a digital treatment for a mental health condition. But that landmark comes amid many questions about whether such digital therapeutics deliver their advertised results — and whether they can gain traction with clinicians, insurers, and patients. Prescription digital therapeutics have yet to see a blockbuster success, and several companies have gone out of business trying to create one.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： Why CTE doesn’t keep Americans from enjoying the Super Bowl

WSS

Hospitals are dialing back on venture capital investing

Bird flu researchers hone in on Finland’s mink farms

The Biogen Aduhelm mess could happen again

Novo Nordisk touts Wegovy study, but still struggling with supply

Cano Health’s bankruptcy is a warning for Medicare Advantage

Novo Nordisk touts Wegovy study, but still struggling with supply

focus

fashion

Wikipedia

Continuity nursing helped my family in our darkest PICU moments

Timeline: How the deadly wildfires took over Maui day by day

Heart attack and stroke risk calculators need revising

Padmanee Sharma of MD Anderson at center of lawsuit over credit

BioMarin wins approval for gene therapy to treat hemophilia A

Senators push IRS to launch nonprofit hospital probe

23andMe had bad news about my health. I wish a person had delivered it

Readout LOUD: Venture capital, Gilead, and more M&A

Affirmative action in medical school literally saved lives

BMS, looking to build heart drug business, turns to AI for diagnosis

focus

Maui wildfire now ranks as the fifth

Biden administration begins canceling student loan debt for 804,000 borrowers

Gritstone Bio's cancer vaccine test, and more on Novartis' deal

Vyjuvek, a gene therapy for skin wounds, restored vision in one boy

Gene therapy for Afghan refugees’ infant will be fully covered

Schizophrenia gene found to be linked to cells' energy dysfunction

leisure time

entertainment

hotspot

focus